EODData

MEMBERSHIP REGISTER LOG IN

FRA, NVV1: Novavax Inc

07 Nov 2025
LAST:

6.437

CHANGE:
 0.15		OPEN:
6.539		HIGH:
6.539		ASK:
0.000		VOLUME:
10.9K
CHG(%):
2.32		PREV:
6.590		LOW:
6.341		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 256.5396.5396.3416.43710.9K
06 Nov 256.6746.9546.5006.5903.2K
05 Nov 256.5926.6736.5926.6737.9K
04 Nov 256.8136.8346.5756.5752.8K
31 Oct 257.2667.2667.2407.240100
30 Oct 257.1587.3177.1587.3171.4K
29 Oct 257.3287.3287.2637.2633.3K
28 Oct 257.5187.5187.3267.339468
27 Oct 257.3587.4577.3587.4571.1K
24 Oct 257.1967.3797.1967.3791.0K

COMPANY PROFILE

Name:Novavax Inc
About:Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:700 Quince Orchard Road, Gaithersburg, MD, United States, 20878
Website:https://www.novavax.com
ISIN:US6700024010
LEI:529900J4GJHPEPQ23205

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:3.51 
Forward P/E:0.21 
PEG Ratio:-0.09 
Price to Sales:1.06 
Price to Book:29.19 
Profit Margin:0.39 
Operating Margin:0.44 
Return on Assets:0.15 
Return on Equity:0.30 
Revenue:936.22M 
EBITDA:353.67M 
Shares:162.42M 
Market Cap:1.046B 

TECHNICAL INDICATORS

MA5:6.704.1%
MA10:7.039.2%
MA20:7.1811.6%
MA50:7.1310.8%
MA100:6.724.3%
MA200:6.714.2%
RSI14:41.62
WPR14:-100.00 
MTM14:-1.10
ROC14:-0.15 
ATR:0.24 
Week High:7.2712.9%
Week Low:6.341.5%
Month High:8.2027.4%
Month Low:6.344.2%
Year High:11.2174.2%
Year Low:4.6139.8%
Volatility:55.35 

RECENT SPLITS

Date Ratio
10 May 20191-20